Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.
Zarling LC, Stevenson PA, Soma LA, Martino CH, Percival MM, Halpern AB, Ghiuzeli CM, Becker PS, Oehler VG, Cooper JP, Orozco JJ, Hendrie PC, Walter RB, Estey EH, Cassaday RD.
Zarling LC, et al. Among authors: soma la.
Eur J Haematol. 2023 Dec;111(6):863-871. doi: 10.1111/ejh.14089. Epub 2023 Sep 5.
Eur J Haematol. 2023.
PMID: 37670560